A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma

Nasopharyngeal carcinoma (NPC) is a serious and highly invasive epithelial malignancy that is closely associated with Epstein—Barr virus (EBV). Due to the lack of therapeutic vaccines for NPC, we selected EBV latent membrane protein 2 (LMP2) as a preferable targeting antigen to develop a lipid-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Mengran, Duan, Xing, Peng, Xingchen, Jin, Zhaohui, Huang, Hai, Xiao, Wen, Zheng, Qian, Deng, Yongqi, Fan, Na, Chen, Kepan, Song, Xiangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tsinghua University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807982/
https://www.ncbi.nlm.nih.gov/pubmed/36618068
http://dx.doi.org/10.1007/s12274-022-5254-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807982/
https://www.ncbi.nlm.nih.gov/pubmed/36618068
http://dx.doi.org/10.1007/s12274-022-5254-x

Ejemplares similares